Navigation Links
Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACC's 57th Annual Scientific Session
Date:3/26/2008

Presentation by Leader of Innovative Scripps Genomic Medicine Program to

Include Data on Novel Genomic Markers for Cardiac Disease

SAN DIEGO, March 26 /PRNewswire/ -- Eric J. Topol, M.D., chief academic officer of Scripps Health and director of the Scripps Translational Science Institute, will present a late-breaking lecture about advancements in the genomics of cardiovascular disease at the American College of Cardiology's (ACC) 57th Annual Scientific Session in Chicago.

Dr. Topol's presentation on March 31 will include data concerning new, compelling genomic markers for myocardial infarction, coronary artery disease, atrial fibrillation and abnormal lipoproteins. A panel discussion about the progress, limitations, caveats and future issues in cardiovascular genomic medicine will follow the presentation.

Who: Eric J. Topol, M.D., Chief Academic Officer, Scripps Health;

Director of Scripps Translational Science Institute; Professor of

Translational Genomics, The Scripps Research Institute

What: Late-breaking lecture about advancements in the genomics of

cardiovascular disease

When: 3:30 p.m.-4:30 p.m. CDT, March 31

Where: North Hall B1, McCormick Place, Chicago

About Scripps Genomic Medicine

An initiative of Scripps Health and The Scripps Research Institute, Scripps Genomic Medicine is an innovative program in which genomic researchers, clinicians and other specialists are working side-by-side to advance medicine. Current projects include the genotyping of tens of thousands of individuals of diverse ancestry to identify and define genes that are responsible for major disease and the underpinnings of health. Through The Scripps Translational Science Institute, this basic research will be translated into drug discovery programs and, ultimately, clinical trials. These trials, launched through Scripps Advanced Clinical Trials, will test individualized treatment and prevention strategies in collaboration with pharmaceutical, medical device, biotechnology and diagnostic companies. For more information, visit http://www.scrippshealth.org/genomic.

About Scripps Health

Founded in 1924 by philanthropist Ellen Browning Scripps, Scripps Health is a non-profit community health system based in San Diego. Scripps treats a half-million patients annually through the dedication of 2,600 affiliated physicians and 11,000 employees among its five acute-care hospital campuses, home health care services, and an ambulatory care network of clinics, physician offices and outpatient centers. Recognized as a national leader in the prevention, diagnosis, and treatment of disease, Scripps is also at the forefront of clinical research and graduate medical education. For more information, visit http://www.scrippshealth.org.


'/>"/>
SOURCE Scripps Health
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Charles A. Peck, M.D., F.A.C.P. Joins LifeMasters as New Medical Director Focused on Client Experience
4. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
5. William F. Balistreri, M.D., honored with Distinguished Service Award by AASLD
6. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
7. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
8. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
9. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
10. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
11. AtriCure to Present at Roth Capital Partners 2007 New York Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: